(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone manufacturers
|
| | (3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone Basic information |
| Product Name: | (3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone | | Synonyms: | (3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone;2(3H)-Furanone, 3-(β-D-glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-, (3S,4S)-;(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis(4-hydroxy-3-methoxyphenyl)methyl-2(3H)-furanone;Nortrachelogenin-8'-O-beta-glucoside;Nortrachelogenin-8'-O-β-glucoside;Nortrachelogenin 8' O beta glucoside,Nortrachelogenin8'Obetaglucoside;Nortrachelogenin-8'-O-β-D-glucopyranoside;Nortrachelogenin-8''-O-beta-glucoside | | CAS: | 858127-38-5 | | MF: | C26H32O12 | | MW: | 536.53 | | EINECS: | | | Product Categories: | | | Mol File: | 858127-38-5.mol | ![(3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone Structure](CAS/20211123/GIF/858127-38-5.gif) |
| | (3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone Chemical Properties |
| Boiling point | 814.1±65.0 °C(Predicted) | | density | 1.51±0.1 g/cm3(Predicted) | | pka | 10.02±0.20(Predicted) |
| | (3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone Usage And Synthesis |
| Uses | Nortrachelogenin-8'-O-β-glucoside is a natural product that can be isolated from the dried roots of Pulsatilla koreana. Nortrachelogenin-8'-O-β-glucoside inhibits cancer cell proliferation and reduces hormone dependence[1][2]. | | References | [1] Lee S, et al. Sortase A inhibitory metabolites from the roots of Pulsatilla koreana. Bioorg Med Chem Lett. 2014 Jan 1;24(1):44-8. DOI:10.1016/j.bmcl.2013.12.006 [2] Chen W, et al. Kangquan Recipe Regulates the Expression of BAMBI Protein via the TGF-β/Smad Signaling Pathway to Inhibit Benign Prostatic Hyperplasia in Rats. Evid Based Complement Alternat Med. 2019 May 2;2019:6281819. DOI:10.1155/2019/6281819 |
| | (3S,4S)-3-(β-D-Glucopyranosyloxy)dihydro-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone Preparation Products And Raw materials |
|